Adaptive Biotechnologies Corporation ADPT

29.43 (0.14) (0.47%) as of 25 Sep
Market cap
$4.7B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
226.98 222.29 346.40 498.20 353.06 688.27 576.87 165.02 192.15
Receivables
50.37 41.73 37.97 40.06 17.41 10.05 12.68 4.81 5.58
Inventory
9.82 8.44 14.45 14.45 19.26 14.06 9.07 7.84 4.79
Total current assets
300.19 283.75 410.19 562.15 402.75 726.91 612.69 180.72 205.25
Property, Plant, Equpment (Net)
34.11 48.62 68.23 83.45 85.26 39.69 60.36 19.13 13.95
Long-Term Investments
13.23 33.66 — 2.00 217.15 118.53 105.44 0.00 8.91
Goodwill and Intangible Assets (Total)
120.70 122.40 124.10 125.80 127.50 129.20 130.90 132.60 134.30
Long-term assets (Other)
3.90 5.18 6.52 4.46 3.01 2.74 2.92 0.25 0.09
Total non-current assets
212.55 255.62 250.95 294.47 520.60 389.50 299.61 151.97 157.24
Total Assets
512.74 539.38 661.13 856.62 923.34 1,116.41 912.30 332.69 362.49
Accounts Payable
6.47 7.27 7.72 8.08 3.31 3.24 4.45 1.79 1.96
Accrued Expenses
24.69 24.00 22.28 28.36 24.99 25.11 12.50 7.20 4.11
Current Revenue (Deferred)
45.19 55.69 48.63 64.12 80.46 73.32 61.37 13.80 14.93
Other current liabilities
4.64 0.87 — 92.00 105.00 98.00 74.00 21.00 19.00
Total current liabilities
89.92 98.05 88.02 109.79 113.81 105.20 78.31 22.80 21.00
Long Term Debt (Total)
— — — 224.00 107.00 104.00 36.61 561.00 562.00
Non-current Revenue (Deferred)
1.01 27.26 44.79 58.60 98.75 163.62 226.25 6.81 4.39
Liabilities (Preferred Stock)
— — — — — — — 0.34 0.34
Non-current Liabilities (Other)
126.59 132.43 130.66 125.36 — 0.00 0.09 6.00 0.03
Total non-current liabilities
197.82 238.84 264.84 282.73 205.44 267.95 262.95 7.14 4.77
Total liabilities
287.74 336.89 352.86 392.52 319.24 373.15 341.26 29.94 25.77
Additional Paid In Capital
1,581.85 1,506.35 1,452.50 1,387.35 1,324.01 1,253.97 935.83 37.90 24.97
Preferred Stock (Total)
— — — — — — — 560.86 561.33
Common Stock (Net)
0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Retained Earnings
(1,363.32) (1,303.82) (1,144.33) (919.08) (718.89) (511.61) (365.48) (295.91) (249.42)
Common Equity (Total)
225.00 202.49 308.28 464.10 604.10 743.27 571.04 (258.11) (224.62)
Shareholders Equity (Total)
225.00 202.49 308.28 464.10 604.10 743.27 571.04 302.75 336.72
Shareholders Equity and Liabilities (Total)
512.74 539.38 661.13 856.62 923.34 1,116.41 912.30 332.69 362.49
Shares (Common)
153.78 147.77 145.08 143.11 141.39 137.65 125.24 12.84 12.21
Shares (Preferred)
— — — — — — — 92.79 92.66
Shareholders Equity (Tangible)
104.30 80.09 184.18 338.30 476.60 614.07 440.14 170.15 202.42
Net Debt
(226.98) (222.29) (346.40) (274.20) (246.06) (584.27) (540.26) 395.98 369.85
Total Debt
— — — 224.00 107.00 104.00 36.61 561.00 562.00

Fold the line items

In millions of $ except per-share values · columns are period end dates